About the Company
We do not have any company description for Pandion Therapeutics Inc at the moment.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
37
Exchange
NASDAQ/NGS (GLOBAL SELECT MARKET)
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PAND News
Analyzing the Price-to-Earnings Ratio of Cullinan Therapeutics Inc (CGEM)
Based on Cullinan Therapeutics Inc (CGEM), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -37.4. The debt to equity ...
We don't have any news on Pandion Therapeutics Inc at the moment.
Loading the latest forecasts...